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Progesterone and estrogen are critical regulators of uterine receptivity. To facilitate uterine remodeling for embryo
attachment, estrogen activity in the uterine epithelia is attenuated by progesterone; however, the molecular
mechanism by which this occurs is poorly defined. COUP-TFII (chicken ovalbumin upstream promoter transcription
factor II; also known as NR2F2), a member of the nuclear receptor superfamily, is highly expressed in the uterine
stroma and its expression is regulated by the progesterone–Indian hedgehog–Patched signaling axis that emanates
from the epithelium. To further assess COUP-TFII uterine function, a conditional COUP-TFII knockout mouse was
generated. This mutant mouse is infertile due to implantation failure, in which both embryo attachment and uterine
decidualization are impaired. Using this animal model, we have identified a novel genetic pathway in which BMP2 lies
downstream of COUP-TFII. Epithelial progesterone-induced Indian hedgehog regulates stromal COUP-TFII, which in
turn controls BMP2 to allow decidualization to manifest in vivo. Interestingly, enhanced epithelial estrogen activity,
which impedes maturation of the receptive uterus, was clearly observed in the absence of stromal-derived COUP-TFII.
This finding is consistent with the notion that progesterone exerts its control of implantation through uterine
epithelial-stromal cross-talk and reveals that stromal-derived COUP-TFII is an essential mediator of this complex cross-
communication pathway. This finding also provides a new signaling paradigm for steroid hormone regulation in
female reproductive biology, with attendant implications for furthering our understanding of the molecular
mechanisms that underlie dysregulation of hormonal signaling in such human reproductive disorders as endometriosis
and endometrial cancer.
Citation: Kurihara I, Lee DK, Petit FG, Jeong J, Lee K, et al. (2007) COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity. PLoS Genet
3(6): e102. doi:10.1371/journal.pgen.0030102
Introduction
Establishment of uterine receptivity is mandatory for
successful embryo apposition, attachment, and implantation;
failure to manifest this uterine state is an underlying cause of
most pregnancy failures in women. A multitude of signaling
molecules have been shown to play key roles in the
elaboration of this uterine response through mesenchymal–
epithelial interaction. Among numerous factors involved in
these primary events of pregnancy, two steroid hormone
receptors, progesterone receptor (PR) and estrogen receptor
(ER), and their cognate ligands, undoubtedly play central
roles in this biological process [1–3]. Although estrogen
activity is essential for an integrated uterine response, it has
been shown that excessive estrogen activity can prematurely
close the implantation window [4], suggesting that estrogen
activity is tightly controlled during the peri-implantation
period to allow normal development of the receptive uterus.
Importantly, progesterone is known to attenuate estrogen-
induced gene expression in uterine epithelial cells [5].
Intriguingly, this suppression is mediated by stromal proges-
terone receptors [6,7], suggesting that the coordinated action
of estrogen and progesterone depends on crosstalk between
the epithelial and stromal compartments of the uterus.
Although the inhibitory effect of progesterone on epithelial
estrogen activity has been described [6,7], the mechanism by
which progesterone suppresses estrogen action remains
poorly deﬁned.
Lydon et al have shown that female PR-null mice are
infertile [8]. The expression of Indian hedgehog (Ihh), a gene
highly expressed in the uterine epithelium, is greatly reduced
in these null mutants, indicating that Ihh is a downstream
target of the progesterone receptor [9]. To understand the
role of Ihh in reproduction, conditional null mutant mice of
Ihh were generated [10]. These mutants exhibit defects in
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epithelial Ihh regulates the decidual response through
Patched/Smoothened (Ptch/Smo) signaling in the stroma.
Recently, it has been shown that COUP-TFII (chicken
ovalbumin upstream promoter transcription factor II; also
known as NR2F2) is a downstream target of Ihh in the uterine
tissue [9,10]. COUP-TFII is highly expressed in the uterine
stromal compartment, and its expression is signiﬁcantly
reduced in the Ihh mutant mice, suggesting that COUP-TFII
might mediate the effects of Ihh signaling in the uterine
stroma [10]. This notion is consistent with our previously
ﬁndings that COUP-TFII is a downstream target of sonic
hedgehog (Shh) signaling [9–13] and conditional ablation of
COUP-TFII in the foregut mesenchyme resembles Shh-null
mutant phenotypes [14].
COUP-TFII belongs to the orphan nuclear receptor
superfamily, and has been well characterized [15,16]. Genetic
ablation of COUP-TFII results in early embryonic lethality due
to cardiovascular defects [17]. COUP-TFII heterozygous
female mice have shown signiﬁcant reduced fecundity, which
is attributed to ovarian and uterine defects [18], but the
uterine-speciﬁc function of COUP-TFII remains largely
undeﬁned. We have recently established a COUP-TFII
ﬂox/ﬂox
mouse model in order to generate tissue- or cell-lineage–
speciﬁc knockouts of COUP-TFII. Phenotypes exhibited by
conditional mutants lacking COUP-TFII in endothelial cells
[19], limbs [20], stomach [14], or diaphragm [21] are all
consistent with the notion that COUP-TFII might play an
important role in reciprocal epithelial–mesenchymal cellular
cross-talk.
To deﬁne COUP-TFII uterine function, we have ablated
COUP-TFII speciﬁcally in cell lineages of the uterus that
express PR by crossing COUP-TFII
ﬂox/ﬂox with PR-Cre knockin
mice [22]. Ablation of COUP-TFII in the uterine stroma
results in decidualization failure, resembling the conditional
ablation of Ihh. In addition, we showed that the expression of
bone morphogenetic protein 2 (BMP2) is greatly reduced in
the COUP-TFII mutants, and that reintroduction of BMP2
into uterine horn rescues the decidualization defects. Thus,
we established a genetic pathway in which progesterone
receptor regulates Ihh, which in turn regulates COUP-TFII
through Ptch/Smo signaling, and ﬁnally, COUP-TFII regulates
BMP2 to confer decidualization in the uterus. Surprisingly,
we also found that ER activity and target gene expression in
the uterine epithelial cells are markedly elevated in condi-
tional COUP-TFII knockout mice, which alters the window of
receptivity and affects embryo attachment and implantation.
Since stromal PR has been implicated to suppress epithelial
ER activity, we further asked whether stromal PR expression
is downregulated in the COUP-TFII conditional mutants.
Indeed, PR expression is reduced signiﬁcantly in the uterine
stroma, while no obvious change is seen in the epithelium.
This ﬁnding indicates an indispensable role for stromal
COUP-TFII in the maintenance of progesterone suppression
of uterine epithelial ER activity, a prerequisite for the
establishment of normal uterine receptivity. This study also
substantiates the importance of epithelial–stromal cross-
communication and sheds new light on a complex signaling
circuit that spans the uterine epithelial–stromal divide that is
indispensable for the development of the receptive uterus
and subsequent decidualization. In addition, not only does
this ﬁnding further our understanding of steroid hormonal
control of uterine receptivity, but it provides a novel
signaling paradigm for steroid hormonal dysregulation
shown to underlie such female reproductive pathologies as
endometriosis and endometrial, ovarian, and breast cancers.
Results
COUP-TFII Expression Is Efficiently Ablated in the Uterus of
COUP-TFII Mutant Mice
Conditional knockout mice of COUP-TFII, PR
Cre/þ COUP-
TFII
ﬂox/ﬂox were generated by crossing PR-Cre knockin mice
with COUP-TFII
ﬂox/ﬂox mice. PR is highly expressed in the
uterine stroma and epithelium, while COUP-TFII is highly
expressed in the stroma, but rarely expressed, if ever, in the
uterine epithelium [18,22]. Immunohistochemistry of the
reproductive tract indicated that COUP-TFII is efﬁciently
ablated in the stroma of the mutant uterus by the PR-Cre
(Figure 1A and 1B). It is also evident from this ﬁgure that
COUP-TFII is highly expressed in the stroma compartment
but is hardly detectable in the luminal and the glandular
epithelia of the uterus. In contrast, PR is expressed in the
granulosa cells, while COUP-TFII is expressed in the theca
cells of the ovary [18,22]. Since PR and COUP-TFII are not
expressed in the same cell, COUP-TFII is not ablated in the
theca cells. As expected, the expression of COUP-TFII in the
theca cells of the ovary is not altered in the conditional
COUP-TFII mutants comparison with controls as shown by
immunostaining (Figure 1C–1E). To ensure there is no
disruption of ovarian function in COUP-TFII mutants, we
transferred ovaries from control and mutant mice to wild-
type recipients and observed reproduction for a 6-mo period.
Healthy newborns were yielded from PR
Cre/þ COUP-TFII
ﬂox/ﬂox




ﬂox/þ ovaries (Table 1). In addition, the litter
size from the mutant ovaries was not signiﬁcantly reduced
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Author Summary
Pregnancy is established and maintained through a series of
precisely choreographed cellular and molecular events that are
controlled by two sex hormones, estrogen and progesterone. Both
hormones exert their actions through their distinct nuclear
receptors. During the peri-implantation period, estrogen activity is
attenuated by progesterone to facilitate epithelial remodeling and
embryo attachment, but the detailed molecular mechanism of how
this process is achieved remains largely undefined. COUP-TFII
(chicken ovalbumin upstream promoter transcription factor II; also
known as NR2F2), a member of the nuclear receptor superfamily, is
highly expressed in the uterine stroma, and its expression is
controlled by progesterone–Indian hedgehog–Patched signaling
from the epithelium to the stroma. To assess the uterine function of
COUP-TFII, uterine-specific COUP-TFII knockout mice were gener-
ated. These mutant mice are infertile due to failure of implantation.
We identified a novel genetic pathway in which the epithelial Ihh
regulates the stroma COUP-TFII to control BMP2 and regulates
decidualization. Interestingly, enhanced epithelial estrogen activity,
which impedes the maturation of receptive uterus, was clearly noted
in the absence of COUP-TFII. This finding reveals that COUP-TFII
plays a critical role in maintaining the balance between estrogen
and progesterone activities to establish proper implantation. This
finding also provides new insights into women’s health care
associated with uncontrolled estrogen activity, such as breast
cancer and endometriosis.Figure 1. COUP-TFII Is Efficiently Deleted by PR-Cre, and Resulting Mutants Are Infertile
However, COUP-TFII is not deleted in the ovary and, thus, mutants exhibit no ovarian defects.
(A–B) Immunohistological detection of COUP-TFII in the uterus. (A) Control, 4.5 dpc. COUP-TFII is highly expressed in the endometrial stroma, but is
undetectable in the epithelial compartment. (B) Mutant, 4.5 dpc. COUP-TFII expression is efficiently ablated in the mutant uterus.
(C–D) Immunohistological detection of COUP-TFII in the ovary. (C) Control, 4.5dpc. COUP-TFII is highly expressed in the theca cell layer. (D) Mutant,
4.5dpc. COUP-TFII expression is maintained in the theca cell layer.
(E) The gene expression of COUP-TFII, assayed by quantitative real-time RT-PCR. COUP-TFII expression is efficiently ablated in the uterus but not affected
in the ovary. White bar: control; black bar: mutant. *p , 0.001 (t-test, n ¼ 9).
(F) Summary of breeding studies. PR
Cre/þ COUP-TFII
flox/flox mutants are infertile, while both controls are normal in fertility.
doi:10.1371/journal.pgen.0030102.g001
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The Roles of COUP-TFII in the Uteruscompared with that of controls, indicating that the PR
Cre/þ
COUP-TFII
ﬂox/ﬂox females have no ovarian defects (Table 1).
Thus, the implantation failure observed in our conditional
mutants is likely due to impaired uterine, but not ovarian,
function.




ﬂox/ﬂox mutant mice and COUP-TFII
ﬂox/ﬂox
control mice were mated with wild-type males (B6SJLF1;
Taconic) and observed for 6 mo to compare breeding
capacity. PR-Cre mice were also used as a control to
distinguish the contribution of the PR-Cre allele. Pups were
not born from mutant females, while both types of controls
gave birth regularly (Figure 1F), indicating that ablation of
COUP-TFII in the uterus leads to infertility. The hormone
proﬁle during pregnancy showed no signiﬁcant difference in
estradiol (control, 45.3 6 3.8 pg/ml; mutant, 47.9 6 3.2 pg/ml;
n ¼ 14, 3.5 d postcoitus [3.5 dpc]) and progesterone levels
(control, 15.8 6 4.4 ng/ml; mutant, 18.6 6 2.9 pg/ml; n ¼ 12,
3.5 dpc) between mutants and controls, further supporting
the fact that PR
Cre/þ COUP-TFII
ﬂox/ﬂox mice have no obvious
ovarian defect as stated above (Figure 1C–1E; Table 1).
To dissect the cause of infertility, we examined whether
embryos properly attach to the uterine lumen, an early event
of pregnancy that is initiated at midnight of pregnancy day 4
(4 dpc). We dissected mice on the morning of pregnancy day 5
(4.5 dpc) and counted the number of implantation sites by
injecting Chicago Blue dye. Implantation sites were not
detected in the mutant uterine horns, while normal implan-
tation sites were scored in the controls (Figure 2A–2C).
Histological examination also showed embryos failed to
attach to the uterine lumen of mutant mice, while normal
attachment and induction of the decidual response was
observed in all controls (Figure 2D–2E). Embryo-attachment
failure is most likely caused by an altered uterine receptivity
response in the mutant model, since the blastocyst still
contains an unaltered COUP-TFII allele, and even mutant
embryos are able to implant in wild-type mothers as
previously described [17].
COUP-TFII Mutants Lose the Potential for Decidualization
Decidualization is the subsequent step in the implantation
process [23]. Although it is not possible to compare the
decidual response in natural pregnancies of these mice,
decidualization was assayed after hormonal induction [24].
Induction of decidualization was normal in COUP-TFII
ﬂox/ﬂox
control mice using two types of stimuli (oil injection into the
uterine lumen or needle scratching on the antimesometrial
side of luminal epithelia). Uterine horns of PR
Cre/þ COUP-
TFII
ﬂox/ﬂox mutant mice failed to decidualize under treatment
of either stimuli (Figure 3A, 3B, and 3E), and alkaline
phosphatase activity, an indicator of stromal cell differ-
entiation in response to decidualization, was absent (Figure
3C and 3E). In addition to the failure of decidualization,
stromal cell proliferation is also affected since the size of
mutant uterine horns appear small at 4.5 dpc (Figure 2A and
2B). Immunostaining of phosphorylated histone H3 (phos-
pho-H3) demonstrated that stromal cell proliferation was
signiﬁcantly decreased as indicated by the phospho-H3–
positive cells (Figure 3F and 3G). The numbers of phospho-
H3–positive cells in stroma are quantiﬁed and shown in
Figure 3H. In contrast to the stroma, the numbers of
phospho-H3–positive cells in the epithelia are increased in
the mutant (Figure 3F and 3G). The increase in the numbers
of proliferating cells in the mutant epithelium are quantiﬁed
and shown in Figure 3I. In addition to the decreased
proliferation in the stroma, vessel density visualized by lectin
staining was also lower in the mutant uterus (Figure 3J and
3K). Reduced angiogenesis could partly contribute to the
decrease in size of the uterine horn.
Figure 2. COUP-TFII Mutants Are Defective in Embryo Attachment
PR
Cre/þ COUP-TFII
flox/flox mutants have implantation failure.
(A) Control, 4.5 dpc. Implantation sites are visualized as blue spots.
(B) Mutant, 4.5 dpc. Mutant uterine horns have no implantation sites and
appear small in size.
(C) Summary of implantation study.
(D) Control, hematoxylin and eosin staining (HE), 4.5 dpc. Embryo is
attached to the uterine lumen and the surrounding stroma is permeated
as an initial decidual response.
(E) Mutant, HE, 4.5 dpc. No embryos are attached to the mutant uterine
lumen. A total of 20 embryos were examined in each group.
doi:10.1371/journal.pgen.0030102.g002
Table 1. Ovaries of COUP-TFII Mutant Mice Were Functionally







PR-Cre n ¼ 35 . 8 6 0.8 21.6 6 1.3
PR
Cre/þ COUP-TFII
flox/þ n ¼ 56 . 4 6 0.6 22.5 6 1.3
PR
Cre/þ COUP-TFII
flox/flox n ¼ 74 . 8 6 0.7 21.2 6 0.6
Ovaries from 6-wk-old controls PR
Cre/þ or PR
Cre/þ COUP-TFII
flox/þ or mutant PR
Cre/þ COUP-
TFII
flox/flox mice were transferred to a B6129-F1 female mouse. At 2 wk after transfer, the
mice were mated with B6SJL-F1 male mice for a period of 2 to 6 mo. Each litter was
genotyped.
doi:10.1371/journal.pgen.0030102.t001
PLoS Genetics | www.plosgenetics.org June 2007 | Volume 3 | Issue 6 | e102 1056
The Roles of COUP-TFII in the UterusBMP2 Is the Major Downstream Effector of COUP-TFII for
Decidualization
BMP2 is a known speciﬁc marker for decidualization in the
uterus, and its expression is greatly induced upon decidualiza-
tion [25,26]. To explore the molecular mechanism of decidu-
alization failure in the COUP-TFII mutant mice, we asked
whether expression of BMP2 is altered. Basal Bmp2 expression
levels were unaffected in the mutants in comparison with the
controls. However, the induced expression of Bmp2 upon
decidualization was greatly diminished in the mutant uterus
(Figure 4A). Immunohistochemistry conﬁrmed no stromal
expression of BMP2 in the mutant uterus (Figure 4B and 4C).
The above results suggest that BMP2 is a downstream target of
COUP-TFII that regulates the decidual response. To address
this, we asked whether BMP2 could rescue the decidualization
defect exhibited by the COUP-TFII conditional mutant. Along
with artiﬁcially stimulating the uterus, recombinant human
BMP2 was administered into the uterine lumen. Mice were
dissected 48 h later, and the decidual response was measured.
Figure 3. COUP-TFII Mutants Are Defective in Decidualization
(A–E) PR
Cre/þ COUP-TFII
flox/flox mutants have decidualization failure. (A)
Control, 48 h after stimuli. The right horn (R) was stimulated, and the left
horn (L) was unstimulated. Only right horn is decidualized. (B) Mutant, 48
h after stimuli. Neither right (stimulated) nor left (unstimulated) horn is
decidualized. (C) Control, right horn. Alkaline phosphatase activity is
detected in the decidualized stroma. (D) Mutant, right horn. No alkaline
phosphatase activity is detected in the mutant uterus. (E) Ratio of right
to left horn in weight. Mutant uterine horns fail to decidualize. White bar:
control; black bar: mutant. *p , 0.001 (t-test, n¼6). k–o, cell proliferation
is altered in PR
Cre/þ COUP-TFII
flox/flox mutants.
(F) Control, phospho-H3, 3.5 dpc.
(G) Mutant, phospho-H3, 3.5 dpc. Some positive cells in the epithelium of
the mutant are marked by an arrowhead.
(H–I) Percentage of phospho-H3–positive cells in the stroma (H) and in
the epithelia (I). The number of cells were counted on multiple sections
and averaged in each mouse. Stromal cell proliferation is decreased,
while epithelial proliferation is enhanced in the mutant uterus. White bar:
control; black bar: mutant. *p ¼ 0.007; **p ¼ 0.001 (t-test, n ¼ 7).
(J–K) PR
Cre/þ COUP-TFII
flox/flox mutants have an angiogenesis defect. (J)
Control, 3.5 dpc. Lectin was intravenously administered and adhered to
the inner lumen of vessels. (K) Mutant, 3.5 dpc. Vascular density is
apparently reduced in the mutant uterus.
doi:10.1371/journal.pgen.0030102.g003
Figure 4. BMP2 Mediates COUP-TFII in Decidualization
(A–C) BMP2 induction is diminished in the mutant uterus. (A) The gene
expression of Bmp2 in the stimulated horn (D) and the unstimulated
horn (ND), assayed by quantitative real-time RT-PCR at 48 h after stimuli.
Bmp2 expression is induced by stimuli for decidualization in the control,
but is not sufficiently induced in the mutant uterus. White bar: control;
black bar: mutant. *p , 0.001, (t-test, n¼6). (B) Control, right horn, 72 h
after stimuli. BMP2 is immunohistologically detected in the secondary
decidual zone. (C) Mutant, right horn, 72 h after stimuli. BMP2 is not
detected in the mutant stroma.
(D–I) Decidualization is rescued by the administration of recombinant
human BMP2. (D) Control, 48 h after stimuli. The right horn was treated
with BMP2, and the left horn was treated with BSA (vehicle). Both horns
are decidualized. (E) Control, right horn. (F) Control, left horn. Alkaline
phosphatase activity is detected in both uterine horns. (G) Mutant, 48 h
after stimuli. Only the right horn is decidualized. (H) Mutant, right horn.
(I) Mutant, left horn. Alkaline phosphatase activity is detectable in the
BMP2-treated horn, but not in the BSA-treated horn of mutant uterus.
doi:10.1371/journal.pgen.0030102.g004
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The Roles of COUP-TFII in the UterusBMP2 treatment restored the decidual response in the mutant
uterine horns (Figure 4D and 4G) as measured by the
enhancement of alkaline phosphatase activity in the stimu-
lated horns, while no activity was detected in the vehicle
(BSA)–treated mutant horns (Figure 4E, 4F, 4H, and 4I). These
results strongly support that BMP2 is a major COUP-TFII
effector that lies downstream of COUP-TFII to mediate
uterine decidualization. BMP2 has also been shown as a
downstream target of hedgehog signaling in other tissues
[27,28], and conditional ablation of Bmp2 results in decidual-
ization defects, but embryo attachment is unaffected (Lee et
al., unpublished data). Therein, our ﬁnding provides new
evidence in support of the existence of a uterine Ihh–COUP-
TFII–BMP2 axis that is required for decidualization.
Estrogen Activity Is Enhanced in the Uterine Epithelia of
COUP-TFII Mutants
The lack of embryo attachment indicates that ablation of
COUP-TFII not only affects the physiology of uterine stromal
cells but also affects the endometrial epithelial compartment.
One of the major roles of progesterone is to down-regulate
ER activity in the uterine luminal epithelium, which
consequently opens the uterine receptivity window. Since
COUP-TFII mutants have a receptivity defect (Figure 2A–2E),
we wondered whether COUP-TFII is a mediator of proges-
terone’s suppression of ER activity in the epithelia. If so, ER
activity in this compartment should increase in COUP-TFII
mutants. To address this, the expression level of estrogen-
responsive genes was examined by quantitative real-time RT-
PCR analysis (qRT-PCR). The expression of lactoferrin (Ltf), a
known estrogen-responsive target in the uterine epithelia
[29], is signiﬁcantly elevated in the mutant uterus at 3.5d pc
(Figure 5A). To exclude the possible involvement of other
factors, we also examined the expression of Ltf in mice
exogenously treated with hormones, mimicking 3.5 dpc of
pregnancy (30 h after progesterone and estrogen [Pe]
treatment; see Materials and Methods). Although the fold
changes vary, Ltf expression level is consistently signiﬁcantly
higher in mutant mice (Figure 5B). Immunohistological
staining detected high lactoferrin expression in mutant
epithelia (Figure 5C–5F), demonstrating that estrogen activity
is indeed enhanced in the uterine epithelial compartment.
Other well-documented estrogen-responsive genes in the
Figure 5. COUP-TFII Regulates ER Activity in the Epithelia
Estrogen-responsive genes are upregulated in the mutant uterine epithelia.
(A) The gene expression of Ltf, assayed by qRT-PCR at 3.5 dpc. Ltf expression is high in the mutant uterus. White bar: control; black bar: mutant. *p ¼
0.012 (t-test, n ¼ 6).
(B) Ltf, qRT-PCR, 30 hPe. Ltf expression is consistently high in the mutant uterus. White bar: control; black bar: mutant. *p , 0.001 (t-test, n ¼ 9).
(C) Control, immunohistological detection of lactoferrin, 30 hPe.
(D) Mutant, lactoferrin.
(E) Control, DAPI.
(F) Mutant, DAPI. Upregulated expression of lactoferrin is observed in the epithelial compartment.
(G) The gene expression of C3, assayed by qRT-PCR at 30 hPe. C3 expression is high in the mutant uterus. White bar: control; black bar: mutant. *p ¼
0.015 (t-test, n ¼ 9).
(H) Clca3, qRT-PCR, 30 hPe. Clca3 expression is high in the mutant uterus. White bar: control; black bar: mutant. *p ¼ 0.002 (t-test, n ¼ 9).
doi:10.1371/journal.pgen.0030102.g005
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chloride channel calcium activated 3 (Clca3) [30,31], were also
elevated in the mutant mice (Figure 5G and 5H), indicating
that estrogen activity is upregulated in the uterine luminal
epithelium of mutant mice.
High Estrogen Activity Alters Uterine Receptivity in COUP-
TFII Mutants
Mucin 1 (MUC1) is known to be one of the important
markers determining uterine receptivity [32]. MUC1 is an
estrogen-responsive target, and its expression is attenuated at
the time of implantation to facilitate epithelial remodeling
[33,34]. Persistent expression of MUC1 during the peri-
implantation period prevents uterine receptivity and embryo
attachment [32]. qRT-PCR showed high expression levels of
Muc1 in the mutant uterus (Figure 6A). In addition, immuno-
histochemistry detected high expression levels of MUC1 in the
apical surface of mutant luminal epithelia (Figure 6B and 6C).
These results suggest that high estrogen activity might be the
underlying cause of the uterine receptivity defect displayed by
the mutant model. Consistent with this notion, Clca3, a gene
important for the overproduction of mucus protein [35], is
also shown to be highly upregulated in the mutant uterus
(Figure 5H). Therefore, upregulation of many ER target genes
suggests that stromal COUP-TFII is essential for the PR-
mediated downregulation of ER activity in the epithelium to
open up the receptivity window.
The membrane transformation of uterine epithelia is well
documented as a marker of uterine receptivity [36]. Long
microvilli of the epithelial surface are characteristically
present under estrogen inﬂuence, while progesterone short-
ens these structures. Microvilli ﬂattening occurs before
implantation and is an important process to facilitate embryo
attachment [36]. Electron microscope (EM) studies revealed
that mutant epithelia fail to undergo appropriate remodeling
to ﬂatten the microvilli (Figure 6D and 6E). In addition,
mutant microvilli exhibit increased glycocalyx expression
(Figure 6F and 6G), which is consistent with high expression
of MUC1 [36]. Both MUC1 expression and glycocalyx
formation prevent embryo attachment [34,37,38]. It has been
reported that a series of glycosylation enzymes are involved in
the glycosylation of mucins, and among them, UDP-N-acetyl-
alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl-
transferase 1 (GALNT1) is a key enzyme [39]. We examined
Galnt1 expression in qRT-PCR and observed that its
expression level is increased by 20% (Figure 6H), and, most
remarkably, another glycosylation enzyme Galnt7 expression
is upregulated by almost 70% in the mutant uterus (Figure
6H). Although it has not been well established in the mouse
uterus, activation of GALNT7 catalytic activity requires prior
glycosylation by other enzymes [40], and GALNT7 coopera-
tively functions with GALNT1 [41]. The high expression of
these enzymes might account for hyperglycosylation of the
apical surface of the mutant uterine luminal epithelium.
Another important parameter for uterine epithelial matura-
tion is the presence of desmosomes [36,42,43], adherent
junctions of the lateral plasma membrane. Desmosomes are
normally lost before implantation to facilitate embryo
invasion into the uterine stroma. However, desmosomes are
persistently present in the mutant epithelia (Figure 6I and 6J).
As expected, the expression level of desmocollin-2 (Dsc2), one of
the ubiquitous desmosomal components [44], is high in the
mutant uterus (Figure 6K). This inappropriate regulation of
Dsc2 might contribute to desmosome dysregulation. Taken
together, the high estrogen activity observed in the mutant
epithelium alters the uterine receptivity in the mutant mice,
which is reﬂected by striking structural abnormalities in the
apical–lateral regions of mutant luminal epithelial cell.
Downregulation of PR Expression in the Uterine Stroma of
COUP-TFII Mutants
PR in the stroma has been implicated to play a critical role
in modulating ER activity in the epithelium [6,7]. Since the
Figure 6. Uterine Receptivity Is Disrupted by High Estrogen Activity in
the Mutant Uterine Epithelia
(A) The gene expression of Muc1, assayed by qRT-PCR at 30 hPe. Muc1
expression is high in the mutant uterus. White bar: control; black bar:
mutant. *p ¼ 0.041 (t-test, n ¼ 9).
(B) Control, immunohistological detection of MUC1, 30 hPe.
(C) Mutant, MUC1, 30 hPe. MUC1 is detected in the apical surface of
uterine epithelia, and its expression level is high in the mutants.
(D) Control, EM, 30 hPe. Membrane flattening is observed in the surface
of uterine epithelia.
(E) Mutant, EM, 30 hPe. Mutant uterine epithelia fail to undergo
membrane flattening.
(F) Control, EM, 30 hPe.
(G) Mutant, EM, 30 hPe. Mutant microvilli are excessively coated with
glycocalyx (arrow).
(H) The gene expression of Galnt1 and Galnt7, assayed by qRT-PCR at 30
hPe. The expression of both enzymes is high in the mutant uterus. White
bar: control; black bar: mutant. **p ¼ 0.008, **p , 0.001 (t-test, n ¼ 9).
(I) Control, EM, 30 hPe.
(J) Mutant, EM, 30 hPe. Mutant uterine epithelia exhibit the persistent
presence of desmosome (arrow).
(K) The gene expression of Dsc2, assayed by qRT-PCR at 30 hPe. Dsc2
expression is high in the mutant uterus. White bar: control; black bar:
mutant. *p ¼ 0.001 (t-test, n ¼ 9).
doi:10.1371/journal.pgen.0030102.g006
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The Roles of COUP-TFII in the Uterusactivity of ER is enhanced in COUP-TFII mutants, an
important question is whether ablation of COUP-TFII in the
uterine stroma alters the expression level of stromal PR. To
address this possibility, we used PR-speciﬁc immunostaining
to assess the expression of PR in the uterus of controls and
mutants. The result clearly shows that the expression level of
PR is signiﬁcantly reduced in the stroma of COUP-TFII
mutants (Figure 7A and 7B). In contrast, there is no
signiﬁcant change in the PR expression levels in the luminal
epithelium or the glandular epithelium. This result indicates
that downregulation of PR in the stroma in the absence of
COUP-TFII could disrupt stromal–epithelial interactions and
contribute to the enhanced ER activity.
The Expression of Epithelial ER and Its Coactivator SRC-1 Is
Upregulated in COUP-TFII Mutants
In an attempt to further dissect the molecular mechanism
of enhanced estrogen activity in the mutant uterine epithe-
lium, we ﬁrst asked whether uterine ERa levels are altered in
mutants. qRT-PCR showed a 40% increase in levels of ERa
(Esr1) mRNA in the whole-uterine tissues of COUP-TFII
mutants (Figure 7C). Immunohistological staining using
Figure 7. COUP-TFII Regulates the Expression of ERa and SRC-1 in the Uterine Epithelia
(A–B) Immunohistological detection of PR at 30 hPe. (A) Control (PR
Cre/þ COUP-TFII
þ/þ) (B) Mutant (PR
Cre/þ COUP-TFII
flox/flox). The expression of PR is





(C) The gene expression of Esr1, assayed by qRT-PCR at 30 hPe. ERa expression is increased in the whole mutant uterus. White bar: control; black bar:
mutant. *p ¼ 0.012 (t-test, n ¼ 9).
(D) Immunohistological detection of ERa at 30 hPe of control uterus.
(E) ERa expression is increased in the mutant uterus.
(F) Western blot analysis of ERa, phospho-ERa, and SRC-1 in isolated luminal epithelial cells. Intensity of signals was measured by National Institutes of
Health image software (http://rsb.info.nih.gov/nih-image) and normalized by cyclophilin-A. ERa, phospho-ERa, and SRC-1 were increased 2.5-fold, 2.4-
fold, and 1.6-fold in the isolated luminal epithelia (LE) of the mutant uterus, respectively. *Nonspecific band. Arrow indicates the pERa, which is
confirmed by reprobing with anti-ERa antibody.
(G) Immunohistological detection of phospho-ERa at 30 hPe of control uterus.
(H) Level of pERa is increased in the mutant uterine epithelia.
(I) Immunohistological detection of SRC-1 at 30 hPe of control uterus.
(J) Increased SRC-1 is detected in the epithelial compartment of mutant uterus.
doi:10.1371/journal.pgen.0030102.g007
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pression of ERa in the epithelial compartment of COUP-TFII
mutants (Figure 7D and 7E). To quantify the difference in
expression levels, we isolated uterine epithelia from whole
uterus and examined ERa expression by western blot analysis.
The result showed that ERa expression is increased 2- to 3-
fold in the mutant uterine epithelia (Figure 7F). To further
ask whether these receptors are activated or not, we
examined the phosphorylation status of ERa using antiphos-
phorylated ERa antibody and observed increased phosphor-
ylation of ER in the uterine epithelium of COUP-TFII mutants
(Figure 7F–7H). Increased phosphorylation levels of ER seem
proportional to increased expression levels of ER, but this
modiﬁcation has been shown to couple with growth factor
signaling, which might be controlled under paracrine
mechanism [45] and is less likely to be an autophosphor-
ylation; therefore, this ﬁnding really supports the notion that
stromal–epithelial communication is dysregulated in the
COUP-TFII mutant uterus. In addition to ER, members of
the steroid receptor coactivator (SRC)/p160 family, SRC-1
and SRC-2, have been shown to play a major role in
regulating ER activity and uterine function [46–48]. Thus,
we examined the expression of coactivators by both
immunohistochemistry and western blot analysis. We showed
that SRC-1 is upregulated in mutant uterine epithelia (Figure
7F, 7I, and 7J), while SRC-2 and SRC-3 are unchanged
(unpublished data). Taken together, the increase in ER,
phosphorylated ER, and SRC-1 levels in the mutant uterine
epithelium can together contribute to enhanced uterine ER
activity in the COUP-TFII mutant.
Discussion
Uterine receptivity has been intensely studied in recent
years because of its clinical importance [49,50]. Mouse models
generated by gene-knockout technology revealed that multi-
ple factors are involved in this process [1–3]. Although
individual factors have proven to be essential for uterine
receptivity, most of them are directly or indirectly controlled
by estrogen and/or progesterone. Therefore, we assume that
the balance in activities between these two hormones is a
major determinant of successful uterine receptivity. Indeed
the levels of estrogen used in in vitro fertilization procedures
have recently been suggested as a likely contributor to lower
pregnancy successes when using artiﬁcial reproductive
techniques [51]. This reappraisal prompts the question of
how to control estrogen activity during the peri-implantation
period so that higher success rates with in vitro fertilization
can be achieved. An important step toward addressing this
question is to deﬁne the mechanism by which progesterone
modulates estrogen activity in the uterine epithelium. Under-
standing this pivotal control mechanism would enable the
formulation of better clinical protocols to induce and
preserve the receptive uterus.
Based on the ﬁndings described herein, we propose a new
model to explain estrogen and progesterone control of
uterine implantation. In this model, progesterone activates
the Ihh–COUP-TFII–BMP signaling axis to elicit stromal cell
differentiation that is required for decidualization. Impor-
tantly, COUP-TFII also mediates progesterone-induced sup-
pression of epithelial estrogen action through decreasing
epithelial ER and SRC-1 levels and inhibition of ER activation
(phosphorylation) during the peri-implantation period (Fig-
ure 8). All these effects are likely due to its regulation of
stromal PR level, which was shown to be responsible for the
downregulation of ER activity [6,7]. Because COUP-TFII is
expressed in the stroma, a paracrine mechanism of action is
proposed by which stromal-derived COUP-TFII controls
epithelial ER activity through as-yet-unknown mediator(s)
that transmits the inhibitory signal from the stromal to the
epithelial compartment. Although beyond the scope of this
study, identiﬁcation of this paracrine signal represents the
next most important step to fully understand the complete
circuitry of progesterone/estrogen action in reproduction.
The model of progesterone signaling described here is
most likely oversimpliﬁed. Many other players in both
epithelial and stroma compartments may also participate in
the overall regulation. For example, ER in the stromal
compartment and the very low expression of COUP-TFII, if
any, in the epithelial compartment, may also participate in
some way in this scheme. Only by compartmental-speciﬁc
deletion of these genes can we validate and dissect the
contributions of these proteins to embryo implantation in
the future. As reported previously, COUP-TFII is regulated by
progesterone through Ihh signaling, which emanates from the
epithelial compartment of the uterus, but we should not
underestimate the roles of stromal PR because tissue-
recombinant experimental models have demonstrated that
epithelial estrogen activities are suppressed by stromal PR
[6,7]. Indeed decreased expression of stromal PR is expectedly
observed in COUP-TFII mutant mice, which was examined




ﬂox/ﬂox; Figure 7A and 7B), although detailed regulatory
mechanism of this interdependence has yet to be deﬁned. In
addition, leukemia-inhibiting factor (LIF), which has been
well documented, may also participate in this scheme. Lif-null
mice exhibit defects in embryo attachment, in which the
speciﬁc ultrastructural and immunohistological features
Figure 8. Working Model of COUP-TFII in Mediating Progesterone
Function in the Uterus
Progesterone activates Ihh–Ptch signaling to induce COUP-TFII expres-
sion in the stroma compartment. COUP-TFII, in turn, regulates stromal
cell differentiation (decidualization) through the induction of BMP2.
COUP-TFII also mediates the suppression of epithelial estrogen activity
through inhibiting the expression of SRC-1 and ERa as well as ERa
activation, which allows the uterine epithelia to undergo transformation
and gain receptivity for embryo attachment.
doi:10.1371/journal.pgen.0030102.g008
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phenotypes in Lif-null mice are similar to COUP-TFII mutant
mice, LIF also could be placed in our scheme. LIF is known to
be estrogen responsive; when examined, we did not ﬁnd
signiﬁcant changes in LIF by qRT-PCR and by immunocy-
tochemistry in mutants in comparison to the controls. It is
possible that more complex mechanism underlies our model,
but it is still unequivocal that COUP-TFII has access to the
principal part of steroid receptor regulation in the uterine
biology.
The ﬁnding that COUP-TFII antagonizes ER action is
intriguing. ER has been shown to regulate the expression of
many glycoproteins during the peri-implantation period
[34,53]. Downregulation of the expression of such glycopro-
teins (including MUC1) is known to pave the way for
remodeling of the epithelial surface to facilitate embryo
attachment. Although COUP-TFII has been shown to com-
pete with ER binding in vitro in the regulation of Ltf [54,55],
COUP-TFII is not expressed in the same compartment as
lactoferrin and MUC1, and thus it is unlikely that it regulates
their expression directly in vivo. Using tissue-recombinant
studies, Buchanan et al. showed that epithelial lactoferrin
expression is not only regulated by epithelial ER but also
regulated by stromal ER [56]. This raises the possibility that
COUP-TFII might compete with stromal ER and alter the
epithelial ER function. Another possible mechanism is that
COUP-TFII regulates local estrogen levels, since COUP-TFII
has been shown to compete with SF-1 to regulate aromatase
expression [57]. However, aromatase expression was not
altered in the COUP-TFII conditional mutant mice (unpub-
lished data). We also showed that the expression of ER,
phosphorylated ER, and SRC-1 are all increased in the COUP-
TFII mutants. Enhanced expression of these molecules will no
doubt contribute to the observed increased ER activity and
the subsequent activation of the downstream ER targets.
Since COUP-TFII is highly expressed in the stroma but is
barely detectable in the epithelia, the up-regulation of ER
activity in the epithelium is unlikely a consequence of direct
regulation of the above molecules by COUP-TFII. It is more
likely that the stromal COUP-TFII regulates PR to control a
paracrine signal, which acts through its epithelial receptor to
suppress epithelial ER activity as well as ER and its
coregulator expression. Unlikely as it might be, we can not
exclude the possibility that the low levels of epithelial COUP-
TFII expression is sufﬁcient to synergize with other epithelial
factors to suppress epithelial ER activity directly.
In conclusion, COUP-TFII controls early molecular and
cellular changes in the uterus that are required for embryo
implantation and subsequent decidualization. Based on our
previous observation that COUP-TFII is a mediator of the
Shh pathway in motor neurons and the stomach [11,14], it is
not surprising that COUP-TFII mediates progesterone–Ihh
signaling to regulate decidualization. We also show that BMP2
can rescue the decidual defect elicited by the loss of COUP-
TFII, which places BMP2 downstream of the COUP-TFII
pathway. Unexpectedly, stromal COUP-TFII also promotes
PR expression to mediate progesterone-induced suppression
of estrogen activity in the uterine epithelium; local suppres-
sion of estrogen activity is required to establish a receptive
uterus. Therefore, progesterone control of epithelial estrogen
activity is projected from the stromal compartment via
COUP-TFII through a complex epithelial–stromal cross-
communication pathway. The abnormal increase in estrogen
activity following the removal of COUP-TFII may help our
understanding of the molecular events that control uterine
receptivity as well as female reproductive health.
Materials and Methods
Animals and chemicals. Generation of COUP-TFII
ﬂox/ﬂox mice and
PR-Cre knockin mice has been previously described [14,22]. To obtain
uterine tissues of pregnant mice, we started mating with wild-type
males (B6SJLF1; Taconic, http://www.taconic.com) at 7 wk of age and
designated the day of vaginal plug as pregnant day 1. Ovariectomy
was performed at 6 wk of age and followed by the hormone regimen
as described below. For priming with 1 lgo f1 7 b-estradiol (E2; Sigma-
Aldrich, http://www.sigmaaldrich.com) was dissolved in 1 ml sesame
oil (Sigma-Aldrich), and 0.1 ml was subcutaneously administered in a
single dose for each mouse. For daily treatment of Pe, 10 mg
progesterone (Sigma-Aldrich) and 67 ng 17b-estradiol (nidatory
estrogen(e)) were dissolved in 1 ml sesame oil, and 0.1 ml was
subcutaneously administered in a single dose for each mouse. In the
implantation study, 1% Chicago Sky Blue 6B (Sigma-Aldrich) was
prepared in 0.9% saline, and 0.1 ml was intravenously injected for
each mouse before dissection. For the rescue of decidualization, 25 lg
recombinant human BMP2 (Fitzgerald Industries International,
http://ﬁtzgerald-ﬁi.com) was reconstituted by 10% BSA, and 10 ll
was administered for each uterine horn. All procedures for animal
study were approved by the institutional animal care guidelines at
Baylor College of Medicine. All assays were repeated at least three
times.
Ovary transfer. We followed the ovary transfer procedure




ﬂox/þ mice, or mutant PR
Cre/þ COUP-TFII
ﬂox/ﬂox mice
were isolated and then transferred to a B6129-F1 female mouse. At 2
wk after transfer, the mice were mated with B6SJL-F1 male mice for a
period of 2 to 6 mo. Each litter was genotyped in order to
characterize the origin of the pups. When two litters came from the
transferred ovary, the mating was stopped and the experiment was
considered a success.
Induction of decidualization. The details of this method have been
previously described [24]. Brieﬂy, after 2 wk of ovariectomy, we ﬁrst
primed mice with 100 ng of estradiol (E2) for 3 d and then started the
daily treatment of 1 mg progesterone and 6.7 ng E2 (Pe) 2 d later.
Mechanical stimulation was added 54 h after the ﬁrst Pe treatment (54
hPe), and mice were dissected 48 h later for decidual response
measurement. The same hormone regimen was used for exogenous
hormonetreatmentmimicking3.5dpc.Tissueswereisolatedat30hPe.
Immunohistological staining. Isolated uterine tissues were ﬁxed in
4% paraformaldehyde (PFA)/PBS, dehydrated through graded etha-
nol, and processed for parafﬁn embedding. Primary antibodies used
in this study are as follows: mouse monoclonal anti-COUP-TFII
(1:1,000; Perseus Proteomics, http://ppmx.com), rabbit polyclonal
anti–phospho-H3 (1:200; Upstate Biotechnologies, http://www.
upstate.com), goat polyclonal anti-BMP2 (1:100; Santa Cruz Biotech-
nology, http://www.scbt.com), rabbit polyclonal anti-lactoferrin
(1:5,000; Abcam, http://www.abcam.com), rabbit polyclonal anti-
MUC1 (1:400; Abcam), rabbit polyclonal anti-PR (1:200; Dako, http://
www.dako.com), rabbit polyclonal anti-ERa (1:500; Santa Cruz
Biotechnology), rabbit polyclonal anti–phosphorylated ERa (S118,
1:100; Abcam), and rabbit polyclonal anti–SRC-1 (1:500; Santa Cruz
Biotechnology). Biotinylated antibodies (1:400; Jackson ImmunoR-
esearch, http://www.jacksonimmuno.com) were used as secondary
antibodies, followed by horseradish peroxidase–conjugated strepta-
vidin (1:200; Molecular Probes, http://probes.invitrogen.com), and
signals were developed with 3,39-diaminobenzidine (DAB) substrate
kit (Vector Laboratories, http://www.vectorlabs.com) or Alexa ﬂuor
488–conjugated tyramide signal ampliﬁcation (TSA) kit (Molecular
Probes). Hematoxylin or methyl green (Vector Laboratories) was used
for counterstaining in immunohistochemistry.
Alkaline phosphatase staining. Isolated tissues were ﬁxed in 2%
PFA/PBS, cryoprotected by 30% sucrose/PBS, and embedded in OCT
compounds (Sakura, http://www.sakura.com). The sections were
stained with 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and Nitro
blue tetrazolium chloride (NBT) solution (pH 9.5; Roche, http://www.
roche.com). Nuclear Fast Red (Vector Laboratories) was used for
counterstaining.
Lectin staining. A total of 25 lgb i o t i n y l a t e d - lycopersicon
esculentum lectin (Vector Laboratories) was intravenously injected,
and then uterine tissues were isolated, ﬁxed in 4% PFA/PBS,
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pounds. The sections were incubated in horseradish peroxidase–
conjugated streptavidin, and signals were developed with the TSA kit.
Quantitative real-time RT-PCR. Isolated tissues were quickly
stabilized in RNAlater RNA stabilization reagent (QIAGEN, http://
www.qiagen.com). Total RNA was extracted using an RNeasy Mini kit
(QIAGEN) and reverse transcribed using TaqMan Reverse Tran-
scription Reagents (Applied Biosystems, http://www.
appliedbiosystems.com). Gene expression assay was performed by
running the ABI PRISM 7700 Sequence Derector System (Applied
Biosystems). TaqMan Universal Master Mix reagents and inventoried
primer/probe mixture (Applied Biosytems) were used for the
reaction. The primers/probes used in this study are the following:
Bmp2 (Mm01962382_s1), Ltf (Mm00434787_m1), C3
(Mm00437858_m1), Clca3 (Mm00489959_m1), Muc1
(Mm00449604_m1), Galnt1 (Mm00489148_m1), Galnt7
(Mm00519998_m1), Dsc2 (Mm00516355_m1), Esr1
(Mm00433149_m1), COUP-TFII (Mm00772789_m1). Standard
curves were generated by serial dilution of a preparation of total
RNA, and mRNA quantities were normalized against 18S RNA
determined by using eukaryotic 18S rRNA endogenous control
reagents (Applied Biosystems).
Electron microscopy. Mice were perfused with 2.5% glutaralde-
hyde in 0.1 M cacodylate buffer before isolation of uterine tissues.
Tissues were cut into 1-mm
3 pieces, immersed in 2.5% glutaraldehyde
and 2.0% formaldehyde in cacodylate buffer with 2 mM CaCl2,
washed, and then postﬁxed by 1% OsO4 in 0.1 M cacodylate buffer.
Next, the tissues were dehydrated through graded ethanol then
dehydrated further in propylene oxide, and embedded in Spurr resin.
Ultrathin sections (80 nm) were cut with an MT6000 XL Ultra-
microtome (RMC Inc., http://www.rmcproducts.com), stained with
aqueous uranyl acetate and lead citrate, and examined under a
Hitachi-H7500 TEM (http://www.hitachi-hta.com) at 80 kV.
Isolation of the uterine epithelium. Uterine luminal epithelial cells
were isolated as previously described [59]. Brieﬂy, isolated uteri were
placed into Hanks balanced salt solution (HBSS; Ca
2þ-free, Mg
2þ-
free), and cut into 1-mm segments. The cut uteri were placed into 1%
trypsin/HBSS solution for 1.5 h at 4 8C, and then washed with cold
HBSS. The uteri were placed into 20% FBS/HBSS solution for 5 min,
and washed with cold HBSS. The uteri were incubated with DNase
solution for a minute to break down DNA. The uterine luminal
epithelium was gently removed from the uterine stroma under a
dissecting microscope.
Western blot analysis. The isolated uterine luminal epithelium was
lysed with 13 RIPA buffer (150 mM NaCl, 10 mM Tris-Cl [pH 7.5],
0.1% SDS, 1% Triton X-100, 1% deoxycholate, and 5 mM EDTA)
containing proteinase inhibitors and phosphatase inhibitors. The
whole-uterine luminal epithelial cell lysates were separated on 8%
and 15% SDS–polyacrylamide gels and transferred to a nitrocellulose
membrane (Amersham Biosciences, http://www.amersham.com). The
membranes were blocked in TBST buffer (20 mM Tris [pH 7.6], 137
mM NaCl, and 0.05% Tween 20) containing 1% casein for 1 h and
then incubated overnight at 4 8C in 0.5% casein containing primary
antibody. The membrane was washed several times with TBST buffer
and incubated with horseradish peroxidase–conjugated secondary
antibody. After 1 h, the blot was washed several times with TBST
buffer and developed with ECL reagents (Amersham Biosciences).
Steroid hormone assay. The serum progesterone and estradiol
levels were measured with radioimmunoassay by the core laboratory
of University of Virginia Center for Research in Reproduction Ligand
Assay and Analysis Core.
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